Announced Tue, 21 Jul · 16:49 IST
Q1FY27: Revenue Rs 4,182 Mn, PAT Rs 1,199 Mn; YoY Decline on Delivery Timing
Compliance View source PDF
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹794.00
prior close
₹750.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+1.4-0.4+0.1-1.5-3.1-0.6———————
Up moveDown movePending
AI summary
Anthem Biosciences posted Q1FY27 revenue of Rs 4,182 Mn, down 22.6 percent YoY and 31.5 percent QoQ. CRDMO contributed Rs 3,408 Mn and Specialty Ingredients Rs 774 Mn. EBITDA was Rs 1,755 Mn at 39.6 percent margins and PAT was Rs 1,199 Mn at 27.1 percent margins. Management blamed timing shifts in customer deliveries, said underlying demand is strong and expects backloaded H2 deliveries to drive recovery.
Likely market impact
Stock may see pressure on weak Q1 numbers, though management view of backloaded H2 deliveries and steady margins offers some cushion.